Noema Pharma Closes its Series B Financing Round with USD 147 Million Capital Funding
The new financing will support Noema Pharma’s four active Phase 2 trials, with key data readouts anticipated in 2025.
Noema Pharma | 18/12/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy